'I think we have to step up and help him to understand that he's got to deliver on it'

New Zealand's Coalition Government has adopted a 12-month prescription duration policy, which it estimates will cost NZ$91 million over four years, as more medicines are expected to be dispensed.

Merck has announced it will partner with non-profit research organisation Omico and its groundbreaking national population screening and clinical trial network.

The Medicines Australia chair rightly called for product case studies. Companies should provide them, but also be prepared to defend them, because history suggests the Government and its officials will scrutinise and test each example.

According to the Trump administration's plan, its "immediate steps" to implement the 'MFN' policy essentially amount to asking companies to align the prices paid in the US with those in comparable countries.

The TGA has approved a new medicine that works to remove the build-up of a protein in the brain that can lead to memory loss and impaired thinking.

The Commonwealth has embarked on a significant collection of 'uncertified' PBS claims, with medicine suppliers receiving surprise invoices totalling hundreds of millions of dollars.

The Medicines Australia leadership is articulating a more assertive stance on change based on the public statements of its chair and chief executive.

"As Minister, I have a responsibility to ensure NDIS is not done to or for participants without their input," said NDIS Minister Senator Jenny McAllister.

Bellberry’s CEO, Kylie Sproston, said the 2024 data show that Australia is uniquely positioned to attract global investment in clinical trials due to the high quality of its healthcare institutions and researchers.

Australian experts are urging greater vigilance and awareness of RSV among older adults, particularly grandparents caring for young grandchildren, ahead of the winter season.

The US has cleared for marketing the first in vitro diagnostic device that tests blood to aid in the diagnosis of Alzheimer’s disease.

The concern over private financing dictating the terms of care might be right, but why is it objectionable compared to the government dictating care, which it does every day of the week on its terms that explicitly favour its fiscal objectives?

As Mark Butler assumes portfolio responsibility for disability policy and services, the latest quarterly report from the National Disability Insurance Scheme indicates that the scheme continued to grow rapidly, albeit at a lower rate than previously forecast.

A busy two weeks with an election and the addition of disability and the NDIS to the health portfolio. What does it mean? The credulous reflex response to comparisons between the US and Australian health systems. Why is denying access and out-of-pocket costs in Australia better than what happens in the US?

Lilly Australia spent a week on wellbeing activities as part of the company’s employee wellness initiative 'Week of Wellbeing'.

Readers might consider the challenge of securing the minister's time in the Albanese Government's first term. With the addition of the NDIS, and even with a supporting minister, as the Cabinet representative, Mr Butler's time is going to become even more precious.

Novo Nordisk has announced that Cem Ozenc will be leaving his Australian-based position as general manager of Oceania and will return to the Danish company’s headquarters in Copenhagen.

The discussion over funding weight-loss therapies in the UK has moved to their potential to help address that country's 'worklessness' crisis and boost productivity.

In its third year, the program targets Australian researchers working on pioneering concepts with the potential to advance mRNA medicines.